FDA Reproductive Health Cmte. Line-Up Set; First Priority Will Be WHI Results
Executive Summary
The new roster of FDA's Reproductive Health Drugs Advisory Committee includes two members who have conducted research or educational activities on hormone replacement therapy sponsored by Wyeth
You may also be interested in...
FDA Advisory Cmte. Members Should Be Vetted For Opinions, GAO Says
FDA's selection process for potential advisory committee members should consider the candidates' opinions on relevant topics, a General Accounting Office report recommends
FDA Advisory Cmte. Members Should Be Vetted For Opinions, GAO Says
FDA's selection process for potential advisory committee members should consider the candidates' opinions on relevant topics, a General Accounting Office report recommends
Ortho Oral Contraceptives May Add Folic Acid, New Patent Life
Johnson & Johnson is pursuing a novel strategy to revive its oral contraceptive line: development of a patent-protected combination with folic acid